Circ Cardiovasc Qual
-
Circ Cardiovasc Qual · Nov 2018
Randomized Controlled Trial Multicenter Study Comparative StudyCost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
The CTSN (Cardiothoracic Surgical Trials Network) recently reported no difference in left ventricular end-systolic volume index or in survival at 2 years between patients with severe ischemic mitral regurgitation (MR) randomized to mitral valve repair or replacement. However, replacement provided more durable correction of MR and fewer cardiovascular readmissions. Yet, costeffectiveness outcomes have not been addressed. ⋯ URL: https://www.clinicaltrials.gov. Unique identifier: NCT00807040.